'Transformational’ FY21 results
It is worth reiterating the huge scale of the market opportunity Arqit Quantum addresses....
Read more
Consensus met, record revenue and profits
The trading update for FY21 was encouraging, with results in-line with consensus expectations and...
Read moreM3’s profile rising further
In a spree of positive updates to start 2022, Destiny Pharma begins the year with the profile of...
Read moreTime to buy the dip
Eleco is an IRP-rich firm that is trading at an unjustified discount to peers (2.4x fwd EV/sales vs...
Read moreReasons for optimism
Despite the delay, the results for the year to September were in-line with expectations at the adj....
Read moreWell positioned for strong sales growth in FY2022
ASC announced around 20% sales growth in a FY2021 trading update released today. Sales growth was...
Read moreEarly strategic progress not reflected in valuation
H1 ‘22 results (to 30 Nov ‘21) show steady progress on key metrics, with signs that Time’s refined...
Read moreFY’22 NFI set to climb 7% as investment kicks in
Due to the latest Omicron outbreak, the pace of economic recovery has temporarily hit a soft patch....
Read moreEstablished leader in detection solutions
Kromek delivered a sound, well-managed, H1 performance given industry-wide supply chain and...
Read moreOn track to meet full-year AUM forecast
AUM reached £24.3bn on 31 Dec 21, nine months into the financial year, up £3.4bn or 17% over the...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
